|
Islets of Hope diabetes headline news |
||||
|
|
||
|
Stories and Headline News from the Diabetes Business Community If you copy our list of links for your own site, we'd really appreciate it if you would add a link to our site as well. Your support and mention of www.IsletsofHope.com will help others with diabetes. We now donate 100% of the profits from our website to nonprofit diabetes organizations that purchase insulin, diabetes medications, and supplies for others in need. Current Diabetes News Headlines Busines Archives Menu May 2006 CalbaTech Contributes to Key Effort Supporting Stem Cell Research to Cure Diabetes, Other Major Diseases - CalbaTech, Inc. , an emerging life sciences company concentrating on banking adult stem cells for possible future therapeutic uses and providing products and platforms to the biotech, pharmaceutical research market and to academic institutions, today announced its stem cell subsidiary LifeStem, Inc. contributed five Stem Cell Microbank services to the Los Angeles chapter of the Juvenile Diabetes ... 05/30/2006 BBI targets diabetes as it plans centre of excellence - BRITISH Biocell International is aiming to establish Swansea as a centre of excellence in the treatment of diabetes. BBI Healthcare will market the company's GlucoGel diabetes product for people with hypo-glycaemia, along with a portfolio of other diabetes and healthcare products under acquisition. 05/30/2006 Data From Sangamo BioSciences' Diabetic Neuropathy Program Published In Diabetes - Sangamo BioSciences,Inc. (Nasdaq: SGMO) announced today publication in Diabetes, a journal of the American Diabetes Association, of preclinical animal data demonstrating the efficacy of the Company's ZFP Therapeutic(TM), SB-509, for the treatment of diabetic neuropathy. 05/27/2006 The Global Diabetes Market was Worth $18.6bn in 2005, which was an 11.5% Increase from 2004 sales of $16.6bn - DUBLIN, Ireland, Research and Markets has announced the addition of "The Diabetes Market Outlook to 2011" to their offering. 05/26/2006 CEPTYR, Inc. Begins IND-Enabling Studies with Its PTP-1B Inhibitor for Type II Diabetes - CEPTYR, Inc. today announced that it has formally selected a small molecule clinical candidate to begin IND-enabling studies for type II diabetes. The molecule, CPT633, is a potent inhibitor of PTP-1B, a highly validated target for type II diabetes and obesity. 05/25/2006 Drug giants fight for diabetes market - The drug giants Merck and Novartis could soon be locking horns for dominance in the multibillion-dollar diabetes sector. 05/24/2006 Merck, Novartis battling for diabetes market - The drug giants Merck and Novartis could soon be locking horns for dominance in the multibillion-dollar diabetes sector. 05/24/2006 The Diabetes Market Outlook to 2011 - Diabetes mellitus is a chronic metabolic disorder that is caused by a failure of the body to produce insulin and/or an inability of the body to respond adequately to circulating insulin; type 1 diabetes occurs most often in children or young adults and accounts for 5-10% of the diagnosed diabetes patient population. 05/20/2006 Ryman Healthcare Donates $100,000 to Diabetes NZ - Ryman Healthcare has donated $100,000 to Diabetes New Zealand. The savage disease has been recieving a lot of Press of late due to how serious it is actually becoming. 05/12/2006 Diabetes Trust Fund's $5.5 Million Gift Boosts Community/UAB Partnership - Posted on May 11, 2006 at 3:20 p.m. BIRMINGHAM, Ala. - The Diabetes Trust Foundation (DTF), headquartered in Birmingham, has donated more than $5.5 million toward the establishment of a Comprehensive Diabetes Center at UAB to fight the rising epidemic in the disease. 05/11/2006 California College Gets $16 Million Donation for Stem Cell Center - Sound pioneer Ray Dolby has given $16 million to the University of California, San Francisco, to start a stem cell center that will perform research without federal funds, the school announced Wednesday. 05/11/2006 Sanofi-Aventis profits soar on diabetes drug sale - PARIS, May 5, 2006 (AFP) - Pharmaceutical group Sanofi-Aventis reported on Friday that first-quarter net profit had surged by 53.6 percent with a big injection from the sale of the patent for diabetes treatment Exubera to US group Pfizer. 05/05/2006 Business Coalitions Join AHRQ To Improve The Quality Of Diabetes Care, USA - HHS' Agency for Healthcare Research and Quality today announced a new partnership with three of nation's leading business coalitions designed to help improve the quality of diabetes care within and across communities. The new partnership, Improving Diabetes Care in Communities Collaborative, brings together the Greater Detroit Area Health Council, the MidAtlantic Business Group on Health, and the ... 05/05/2006 Safety concerns halt development of diabetes drug - AstraZeneca P.L.C. said Thursday it has halted work on a new diabetes drug because of safety concerns, its second major dropped project in three months. 05/05/2006 ISTA Pharmaceuticals Reports Simple Model Predicts Treatment Success With Vitrase(R) in Vitreous Hemorrhage Associated with Diabetes - ISTA Pharmaceuticals, ( Nachrichten ) Inc. announced today details of two scientific poster presentations that describe the first predictive model for treatment success with Vitrase(R) (Ovine Hyaluronidase) in managing vitreous hemorrhage associated with diabetes. 05/01/2006 Diabetes Headline News Resources
|
|||||
|
| Contact Us | About IOH | Our Mission | Elizabeth's Story | About the Founder | Join IOH | How To Help | Advertise | Privacy Statement | Site Index | Page Updated 10/01/2006 |
||||
